title: Increased hemolysis after administering intravenous immunoglobulin to a neonate with erythroblastosis fetalis due to Rh hemolytic disease.
authors.affiliation: Divisions of Neonatology and Hematology/Oncology, Department of Pediatrics, University of Utah School of Medicine.|Intermountain Healthcare, Salt Lake City, UT.
authors.forename: Robert D
authors.initials: RD
authors.lastname: Christensen
authors.affiliation: Intermountain Healthcare, Salt Lake City, UT.
authors.forename: Sarah J
authors.initials: SJ
authors.lastname: Ilstrup
authors.affiliation: Intermountain Healthcare, Salt Lake City, UT.
authors.forename: Vickie L
authors.initials: VL
authors.lastname: Baer
authors.affiliation: Intermountain Healthcare, Salt Lake City, UT.
authors.forename: Diane K
authors.initials: DK
authors.lastname: Lambert
mesh_terms: D004899:Erythroblastosis, Fetal / Q000628:therapy*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D010789:Phototherapy; D011247:Pregnancy
chemical_list: D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors